dose etoposid mean dose intens individu dose etoposid infus feasibl extent leukopenia function plasma concentr pretreat wbc wbcp alb perform statu PS bone marrow function transfus requir current studi patient fix dose versu target wbc nadir wbcn total dose averag latter patient decreas mean wbcn variabl wbcn clearanc ml/min bodi surfac area partial respons patient hepatoma non-hodgkin lymphoma dose mean dose intens incid life-threaten toxic due decreas variabl target wbc 